Alternatives to BridgeBio Pharma
BridgeBio Pharma is a Biotech tool: biopharmaceutical company developing transformative medicines for patients with genetic diseases and cancers. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to BridgeBio Pharma
- Website
Lutris Pharma36BiotechSan Diego, United States$170.0MLutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
- Website
Travere Therapeutics51BiotechnologySan Diego, USA$63.0MA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
- Website CACasma Therapeutics46BiotechnologyCambridge, United States$46.0M
Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.
- Website
BeiGene65BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
ANI Pharmaceuticals49BiotechBaudette, United States$670.5MDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
- Website
Braeburn44BiotechPlymouth Meeting, United States$133.0MDevelops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
- Website
NRG Therapeutics42BiotechStevenage, United Kingdom$58.6MA biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
- Website Maasbiolabs37Biotech$1.0M
AI-powered platform accelerating biological research and drug discovery.
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
EyeGate Pharmaceuticals32BiotechWaltham, United States$45.5MClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BenchSci64BiotechToronto, Canada$197.3MAI-powered platform for understanding disease biology and accelerating drug discovery.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website
LabGenius Therapeutics61BiotechLondon, United Kingdom$3.0MAI-driven drug discovery platform for rapid development of novel therapeutics.
Showing the 20 closest matches. See the rest on the BridgeBio Pharma profile.